TROSX Mutual Fund

NAV$18.31

Fund Essentials - as of Apr 30, 2026

Net Assets
$10.2B
Expense Ratio
0.78%
Dividend Yield (Current)
1.86%
Holdings
147
Inception Date
Dec 29, 2006
Fund Family
T.Rowe Price
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+8.78%
1 Year+22.88%
3 Year+16.10%
5 Year+8.45%
10 Year+9.73%

Asset Allocation

Stocks: 100.02%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
ASML:ASAsml Holding Nv2.79%
TTE:PATotal Energies Se1.78%
NOVN:SMNovartis Ag Ordinary Shares1.42%
SAN:MABanco Santander Sa San Sm Equity1.27%
STAN:LNStandard Chartered PLC Shs0.98%
Top 10 Concentration: 12.38%Report Date: Apr 30, 2026
Download all 147 holdings for TROSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.86%
Frequency
Annually
Latest Distribution
$0.25
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how TROSX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

TROSX Mutual Fund Overview

TROSX Mutual Fund (T. Rowe Price Overseas Stock Fund Investor Class) is managed by T.Rowe Price with $10.19B in net assets. TROSX expense ratio is 0.78%, holding 147 positions across sectors including Unknown, Industrials, Health Care. Inception date: 2006-12-29.

TROSX performance shows a YTD return of 8.78%. The 1-year return is 22.88% and the 5-year return is 8.45%. TROSX dividend yield stands at 1.86%, paid annually.

TROSX top holdings include Asml Holding Nv (2.8%), Total Energies Se (1.8%), Novartis Ag Ordinary Shares (1.4%), Banco Santander Sa San Sm Equity (1.3%), Standard Chartered PLC Shs (1.0%). View all TROSX holdings, sector breakdown, or dividend history.

TROSX can be compared against other funds using the overlap calculator or side-by-side comparison tool. TROSX alternatives are available via the screener, along with tax-loss harvesting opportunities.